Category - Executive Moves

Executive Moves

Dr. Tiffany Inglis joins Sera as CMO

Sera Prognostics (NASDAQ: SERA) has announced the appointment of Tiffany Inglis, MD, FACOG, as chief medical officer (CMO). Dr. Inglis brings extensive clinical leadership expertise to Sera. As CMO, she will lead...

October 1, 2025

Executive Moves

Dr. Usman Azam appointed president and CEO of Cue

Cue Biopharma (NASDAQ: CUE) has announced that Usman Azam, MD has been appointed president and CEO of Cue Biopharma, effective today. Daniel Passeri will transition from his current role as CEO to one of strategic...

September 30, 2025

Executive Moves

Onco appoints Dr. Michael Lock to scientific and clinical advisory board

Onco-Innovations (CBOE CA: ONCO; Frankfurt: W1H, WKN: A3EKSZ; OTCQB: ONNVF) has announced the appointment of staff radiation oncologist, Dr. Michael Lock, to its scientific and clinical advisory board. Dr. Lock is a...

September 23, 2025

Executive Moves

Lucid appoints policy leader Danielle Scelfo as SVP, Market Access & Gov’t Affairs

Lucid Diagnostics (NASDAQ: LUCD) announced the appointment of Danielle Scelfo as SVP, Market Access & Government Affairs, reporting to the CEO. With more than 25 years of strategic and operational experience across...

September 16, 2025

Executive Moves

ALX appoints Dr. Barbara Klencke as interim CMO

ALX Oncology Holdings (NASDAQ: ALXO) has announced the appointment of board member Barbara Klencke, MD, as interim chief medical officer, (CMO). According to ALX, Dr. Alan Sandler is departing from the role of CMO and...

September 12, 2025

Executive Moves

MedX appoints Dr. Paul Matts as strategic advisor

MedX Health (TSXV: MDX) has announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist, and educator, as strategic advisor. Dr. Matts is an academic and industry leader, as...

September 9, 2025

Executive Moves

Tatjana Mitchell joins Evolus as CFO

Evolus (NASDAQ: EOLS) has announced the appointment of Tatjana Mitchell as chief financial officer (CFO), effective today. Ms. Mitchell brings more than 20 years of strategic and operational finance leadership across...

September 8, 2025

Executive Moves

Dr. Thomas J. Errico elected electroCore’s chairman of the board; Peter Cuneo retires

electroCore (NASDAQ: ECOR) has announced the election of Thomas J. Errico, MD, as chairman of the board and the departure of Peter Cuneo from its board of directors (BOD). According to electroCore, Mr. Cuneo will...

September 5, 2025

Executive Moves

Adagene appoints Dr. Axel Hoos as executive advisor

Adagene (NASDAQ: ADAG) has announced the appointment of immuno-oncology pioneer, Axel Hoos, MD, PhD, as executive advisor. Most recently, Dr. Hoos served as CEO of Scorpion Therapeutics, which was acquired by Eli Lilly...

September 3, 2025

Executive Moves

Dr. Barbara Krebs-Pohl joins CASI’s BOD

CASI Pharmaceuticals (NASDAQ: CASI) has announced the appointment of Barbara Krebs-Pohl, PhD, as an independent director to its board of directors (BOD). Dr. Krebs-Pohl brings more than 27 years of leadership experience...

September 2, 2025

Category - Executive Moves

Subscribe